Xenon Pharmaceuticals
XENE
#3880
Rank
NZ$4.02 B
Marketcap
$52.53
Share price
-4.27%
Change (1 day)
-24.99%
Change (1 year)

Xenon Pharmaceuticals (XENE) - Cash on Hand

Cash on Hand as of December 2024 : NZ$1.12 Billion

According to Xenon Pharmaceuticals's latest financial reports the company has NZ$1.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Xenon Pharmaceuticals - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$1.11 B10.17%
2023-12-31NZ$1.00 B8.19%
2022-12-31NZ$0.93 B15.44%
2021-12-31NZ$0.80 B229.31%
2020-12-31NZ$0.24 B16.87%
2019-12-31NZ$0.20 B18.01%
2018-12-31NZ$0.17 B189.28%
2017-12-31NZ$61.48 M-33.6%
2016-12-31NZ$92.6 M8.06%
2015-12-31NZ$85.69 M-20.11%
2014-12-31NZ$0.10 B78.88%
2013-12-31NZ$59.96 M-18.01%
2012-12-31NZ$73.13 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.22 B-79.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$75.92 M-93.22%๐Ÿ‡บ๐Ÿ‡ธ USA